QQ客服 官方微博 反馈留言

	MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway
	Zhang, X.; Ke, X.; Pu, Q.; Yuan, Y.; Yang, W.; Luo, X.; Jiang, Q.; Hu, X.; Gong, Y.; Tang, K.
刊名	Oncotarget
	2016
卷号	Vol.7 No.12页码:14569-14585
关键词	MiR-410 NSCLC SLC34A2 Tumorigenesis and development
ISSN号	1949-2553
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1819842
专题	四川大学
作者单位	1.a State Key Laboratory of Biotherapy, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China 2.Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China
推荐引用方式 GB/T 7714	Zhang, X.,Ke, X.,Pu, Q.,et al. MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway[J]. Oncotarget,2016,Vol.7 No.12:14569-14585.
APA	Zhang, X..,Ke, X..,Pu, Q..,Yuan, Y..,Yang, W..,...&Wei, Y..(2016).MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway.Oncotarget,Vol.7 No.12,14569-14585.
MLA	Zhang, X.,et al."MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway".Oncotarget Vol.7 No.12(2016):14569-14585.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。